Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.1007 per EA under NDC 72578000705. Its NADAC has been published 360 times since Aug 7, 2019.
Strength
250 mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578000705
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA206560On Market Since
2/23/2019
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 360 times since Aug 7, 2019, and over the history we have for it it has declined 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1007 per EA |
|---|---|
| All-time high | $0.2230 (Apr 15, 2020) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1096 |
| 52-week low | $0.0623 |
| Median price | $0.1145 |
| Average price | $0.1173 |
| Largest weekly change | -35.7% (Feb 21, 2024) |
| Weeks tracked | 360 |
| Tracking since | Aug 7, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.1007 per EA (NDC 72578000705), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 41.9%. It has been tracked across 360 weekly CMS publications since Aug 7, 2019.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Aug 7, 2019, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.2230 (Apr 15, 2020), with a median of $0.1145 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as METRONIDAZOLE 250 MG TABLET, but none are currently priced below it.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 72578000705) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification